Leaflet GRAZAX 75000 SQ-T sublingual lyophilisate


Indicated for: allergy diagnosis; allergen immunotherapy

Route of administration: sublingual

Substance: standardized allergenic grass pollen extract (allergenic extract)

ATC: V01AA02 (Various | Allergens | Allergen extracts)

Standardized grass pollen allergen extract is used in specific immunotherapy for treating allergies to grass pollen, a common cause of seasonal allergic rhinitis. This treatment helps reduce allergic reactions such as sneezing, nasal congestion, watery eyes, and itching that occur during the pollen season.

The extract is administered as sublingual tablets or drops, following a plan established by an allergist. Doses are gradually increased to accustom the immune system to the allergen and minimize the risk of adverse reactions.

Side effects may include irritation in the mouth or throat, local itching, or swelling. In rare cases, severe allergic reactions can occur, which is why the treatment should be started and monitored by a specialist.

Standardized grass pollen allergen extract is an effective option for patients with severe allergies, helping to reduce symptoms and improve quality of life in the long term.

General data about GRAZAX 75000 SQ-T

  • Substance: standardized allergenic grass pollen extract
  • Date of last drug list: 01-05-2026
  • Commercial code: W68401001
  • Concentration: 75000SQ-T
  • Pharmaceutical form: sublingual lyophilisate
  • Quantity: 30
  • Product type: original
  • Price: 395.71 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ALK-ABELLÓ S.A. - SPANIA
  • Holder: ALK-ABELLÓ A/S - DANEMARCA
  • Number: 14141/2021/01
  • Shelf life: 5 years